Source: Annual Congress 2006 - Therapies and management in chronic airway diseases
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
L. V. Litskevich, I. M. Lapteva, I. G. Lantukhova, O. M. Burak (Minsk, Belarus). Heliox-therapy of patients with execerbation of COPD and community-acquired pneumonia. Eur Respir J 2006; 28: Suppl. 50, 695

Member's Comments

No comment yet.

Related content which might interest you: The comparison of hospitalized healthcare-associated pneumonia with community-acquired pneumonia patients Source: Annual Congress 2010 - Healthcare-associated pneumonia: ventilator-associated pneumonia and pneumonia in hospitalised patients Year: 2010 Analysis of therapy of community-acquired pneumonia (CAP) at the COPD patients Source: Annual Congress 2011 - COPD management Year: 2011 How can I differentiate community-acquired pneumonia (CAP)+COPD patients from acute exacerbation of COPD (AECOPD) patients? Source: International Congress 2015 – Differentiating COPD exacerbations from pneumonia in COPD patients Year: 2015 COPD is associated with increased mortality in patients with community-acquired pneumonia Source: Eur Respir J 2006; 28: 346-351 Year: 2006 Mixed community-acquired pneumonia in hospitalised patients Source: Eur Respir J 2006; 27: 795-800 Year: 2006 Etiology pathogens structure in community-acquired pneumonias and COPD exacerbations Source: Annual Congress 2011 - Role of infection in exacerbations of COPD Year: 2011 Bacteraemia in outpatients with community-acquired pneumonia Source: Eur Respir J 2016; 47: 654-657 Year: 2016 Severity and outcomes of hospitalised community-acquired pneumonia in COPD patients Source: Eur Respir J 2012; 39: 855-861 Year: 2012 Mortality in COPD patients with community-acquired pneumonia: who is the third partner? Source: Eur Respir J 2006; 28: 262-263 Year: 2006 Etiology of community-acquired pneumonia (CAP) in young hospital patients Source: Eur Respir J 2002; 20: Suppl. 38, 356s Year: 2002 Legionella pneumonia in patients hospitalized with community-acquired pneumonia (CAP) in Norway Source: Annual Congress 2012 - Management of severe respiratory infections Year: 2012 Corticosteroids and community-acquired pneumonia Source: Annual Congress 2007 - Corticosteroids and respiratory failure Year: 2007 Duration of antibiotic therapy in hospitalised patients with community-acquired pneumonia Source: Eur Respir J 2010; 36: 128-134 Year: 2010 Is COPD pharmacotherapy associated with increased incidence of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 COPD: what is the frequency and impact of community-acquired pneumonia? Source: Annual Congress 2008 - Community-acquired pneumonia and COPD: what do we know? Year: 2008 Enhanced neutrophil response in patients with chronic bronchitis and community-acquired pneumonia (CAP) Source: Eur Respir J 2002; 20: Suppl. 38, 418s Year: 2002 Management of community-acquired pneumonia in adult outpatients Source: Eur Respir J 2006; 28: Suppl. 50, 377s Year: 2006 Comparison of clinical characteristics between healthcare-associated pneumonia and community-acquired pneumonia in patients admitted into secondary hospitals Source: Annual Congress 2012 - Epidemiology: risk factors and prognosis in respiratory infections Year: 2012 Implications of COPD in patients admitted to the intensive care unit by community-acquired pneumonia Source: Eur Respir J 2006; 27: 1210-1216 Year: 2006 Community-acquired pneumonia (CAP): differences between patients with chronic obstructive pulmonary disease (COPD) and those without COPD Source: Virtual Congress 2020 – Lower respiratory tract infections in clinical practice Year: 2020